OrganOx is a medical technology company, based in Oxford, UK, that has developed metra, a revolutionary device for storing livers at normal body temperatures for extended periods of time, which is commercially available within the EU.
OrganOx was founded in 2008 to exploit technology invented by Professor Peter Friend and colleagues and further developed by Professor Constantin Coussios at the University of Oxford. The normothermic liver perfusion device that has been developed is transforming liver transplantation.
OrganOx is engaged in a further pivotal study in the US and a further study at the Queen Elizabeth Hospital, Birmingham to test the viability and transplant potential of marginal livers.
In the media
6th December 2018
The UK’s first dedicated Vaccines Manufacturing Innovation Centre to be located at The Oxford Science Park
These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, Circassia, OrganOx, OxSonics, Oxford Nanopore Technologies, Sharp Life Science, Oxford Genetics,
5th December 2018
Perfusion Systems Market Insights and Forecast 2022 | Breakdown Data by Manufacturers, Region, Type and Application
Shimadzu Corporation, Accuray Incorporated, Organ Assist B.V., Organ Recovery Systems, Xvivo Perfusion AB, Paragonix Technologies, Inc., TransMedics, Inc., Bridge to Life Ltd., and OrganOx Ltd., Spectrum Laboratories, Inc., Merck KGaA, and
30th November 2018
Medical Perfusion System Market Research Report by Production, Consumption, Export, Import (2013-2018)
Accuray Incorporated, Organ Assist B.V, Xvivo Perfusion AB, Organ Recovery Systems, Paragonix Technologies, Inc, Waters Medical Systems, TransMedics, Inc, Bridge to Life Ltd, OrganOx Ltd Types: Cardiopulmonary Perfusion, Cell Perfusion, Ex